CORC

在结果中检索

CORC

浏览/检索结果: 共9条，第1-9条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Pharmacokinetics-pharmacodynamics and tissue distribution analysis of Low Polar extract of Xiaoyao Powder combined with rat model of chronic unpredictable mild stress 期刊论文
2019, 卷号: 42, 期号: 7-8, 页码: 173-183
作者:  Gao, Xiaoxia;  Wang, Peng;  Wu, Li;  Liu, Jiali;  Fang, Yuan
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Ciclesonide and budesonide suspensions for nebulization delivery: An in vivo inhalation biopharmaceutics investigation 期刊论文
2018, 卷号: 549, 期号: 1-2, 页码: 21-30
作者:  Fu, Tao-Tao;  Zhao, Yun;  Yang, Fei-Fei;  Wen, Han;  Liu, Chun-Yu
收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03
Determination of a PDE4 inhibitor Hemay005 in human plasma and urine by UPLC-MS/MS and its application to a PK study 期刊论文
2018, 卷号: 10, 期号: 11, 页码: 863-875
作者:  Liu, Xuemei;  Chen, Rui;  Zeng, Guanghuai;  Gao, Ying;  Liu, Xiuping
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Development of a validated UPLC-MS/MS method for PK/PD analysis of SYL930 and its two major metabolites in dogs 期刊论文
2017, 卷号: 31, 期号: 2
作者:  Zhao, Manman;  Mi, Jiaqi;  Liu, Xin;  Wang, Yan;  Wu, Xiangmeng
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Quantitative prediction of human pharmacokinetics and pharmacodynamics of imigliptin, a novel DPP-4 inhibitor, using allometric scaling, IVIVE and PK/PD modeling methods 期刊论文
2016, 卷号: 89, 页码: 73-82
作者:  Liu, Dongyang;  Ma, Xifeng;  Liu, Yang;  Zhou, Huimin;  Shi, Chongtie
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
PHARMACOKINETICS (PK) OF SUBCUTANEOUS (SC) AZACITIDINE (AZA) IN CHINESE SUBJECTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS) FROMA PHASE II, OPEN-LABEL STUDY. 会议论文
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015-02-01
作者:  Laille, E.;  Xiao, Z.;  Du, X.;  Dong, Q.;  Songer, S.
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13
PHARMACOKINETICS (PK) OF SUBCUTANEOUS (SC) AZACITIDINE (AZA) IN CHINESE SUBJECTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS) FROMA PHASE II, OPEN-LABEL STUDY. 期刊论文
2015, 卷号: 97, 页码: S81-S81
作者:  Laille, E.;  Xiao, Z.;  Du, X.;  Dong, Q.;  Songer, S.
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/13
Quantitative determination of 2-amino-2-(2-(4'-(2-propyloxazol-4-yl)-[1,1'-biphenyl]-4-yl)ethyl)propan e-1,3-diol and its active phosphorylated metabolite in rat blood by LC-MS/MS and application to PK/PD analysis 期刊论文
2015, 卷号: 407, 期号: 24, 页码: 7511-7516
作者:  Zhao, Manman;  Mi, Jiaqi;  Li, Dan;  Liu, Xin;  Yang, Shuang
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/13
PHARMACOKINETICS (PK) OF CRIZOTINIB (PF-02341066), A DUAL ALK/C-MET INHIBITOR, FOLLOWING ADMINISTRATION OF MULTIPLE ORAL DOSES TO PATIENTS WITH ADVANCED ALK-POSITIVE NSCLC IN CHINA 期刊论文
2012, 卷号: 7, 期号: 11, 页码: S491-S491
作者:  Tan, Weiwei;  O'Gorman, Melissa;  Lanzalone, S.;  Wilner, Keith;  Boyd, Jason
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace